CM082

· AnewPharma

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CM082, covering 2019-02-21 to 2021-02-08. Get the full timeline:

Most recent: Clinical Trial Update: CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma [Phase 3]